À retenir
Among 1158 older adults in the Chicago Health and Aging Project, those reporting 150 or more minutes of activity a week had slower cognitive decline than those reporting none, including when blood neurofilament light chain (NfL) was high (36% slower; β -0.048 vs -0.075). Activity was self-reported at baseline, so this is an association and could partly reflect healthier people being more active.
Study design
Étude de cohorte
Reading basis
Published abstract
Reading focus
Association & confounding
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
Neurofilament light chain (NfL) is a blood marker of nerve cell injury, and it is not well known how physical activity relates to cognitive decline in people with higher or lower levels. The authors examined whether activity was linked to the rate of cognitive decline among older adults, separately by NfL level.
Population et méthode
Cohort study using the Chicago Health and Aging Project (CHAP), a population-based cohort recruited by door-to-door census in 4 Chicago-area communities, with data collected between 1993 and 2012 in cycles of 3 years. The 1158 participants had 2 or more cognitive assessments and at least 1 blood sample for NfL (695 [60%] African American; 728 [63%] female; mean age 77.4 years). Exposures were self-reported physical activity (minutes per week) and serum NfL (pg/mL). Cognitive function was assessed with the East Boston Memory Test, the Symbol Digit Modalities Test and the Mini-Mental State Examination, and mixed-effects regression analyses tested links at baseline and over time. Data were analyzed from January to December 2021.
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1With high NfL (>25 pg/mL), medium activity (<150 minutes a week) was linked to a 12% slower rate of global cognitive decline (β -0.065; 95% CI -0.099 to -0.032) and high activity (≥150 minutes a week) to a 36% slower rate (β -0.048; 95% CI -0.080 to -0.016), compared with low activity, meaning no reported participation (β -0.075; 95% CI -0.108 to -0.041).
- 2With low NfL (≤25 pg/mL), medium activity was linked to 43% slower decline (β -0.025; 95% CI -0.043 to -0.007) and high activity to 30% slower decline (β -0.031; 95% CI -0.048 to -0.014), compared with low activity (β -0.046; 95% CI -0.066 to -0.025).
- 3The authors conclude that physical activity is associated with less cognitive decline in older adults with higher NfL, and that blood biomarkers might help measure the benefit of health behaviors.
Limites et incertitude
- 1Physical activity was self-reported at baseline only, and the low group is people who reported no participation, so recall and health differences may play a role.
- 2The percentages are relative changes in slopes of small cognitive-score declines, so absolute differences are small and the pattern across activity levels is not a clean dose-response (30% vs 43% in the low-NfL group).
- 3A single Chicago cohort, 60% African American with a mean age of 77.4 years, so results may not apply to other groups.
- 4NfL cut-off (25 pg/mL) was used to split the group, and the abstract does not say how it was chosen. This reading is based on the abstract only.
Mise en perspective
Older adults who reported being active, including those with a blood marker suggesting nerve cell injury, tended to lose thinking ability more slowly. This supports staying active in later life, but it cannot show that activity itself slows decline, and NfL is a research measure rather than something to request for yourself. Memory concerns belong with a clinician.
Vos données
A wearable's weekly active minutes give a better measure than the questionnaire used here, and 150 minutes a week is the threshold the study used. Compare monthly totals from the same device, aiming for a steady habit rather than a single big week.
Comprendre ce type de preuve
Exposure precedes follow-up outcomes, but confounding and reverse causation can remain. A hazard ratio is not an individual absolute risk or a demonstrated intervention effect.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Importance
Little is known about the association of serum neurofilament light chain (NfL) concentrations and physical activity with the rate of cognitive decline in older adults.
Objective
To examine the association of physical activity and NfL concentrations with cognitive decline in older adults over time.
Design, setting, and participants
This cohort study used data from the Chicago Health and Aging Project (CHAP), a population-based cohort study that recruited participants through door-to-door census in 4 Chicago-area communities and collected data between 1993 and 2012 in cycles of 3 years. Participants in CHAP who had 2 or more cognitive function assessments and at least 1 blood sample collected for NfL measurement were selected for inclusion in the current study. Data were analyzed from January to December 2021.
Exposures
Self-reported physical activity (minutes per week) and serum NfL concentration (pg/mL).
Main outcomes and measures
Associations of baseline physical activity and NfL concentrations with changes in global cognitive function over time as evaluated using the East Boston Memory Test for episodic memory, the Symbol Digit Modalities Test for perceptual speed, and the Mini-Mental State Examination. Mixed-effects regression analyses were conducted to examine associations at baseline and longitudinally.
Results
The study sample included 1158 participants (695 [60%] African American; 728 [63%] female), with a mean (SD) age of 77.4 (6.0) years and a mean educational level of 12.6 (3.5) years. Among participants with high NfL concentrations (>25 pg/mL), those who engaged in medium physical activity (<150 minutes per week) had a 12% slower rate of global cognitive decline (SD units, or β, -0.065; 95% CI, -0.099 to -0.032) and participants who engaged in high physical activity (≥150 minutes per week) had a 36% slower rate of decline (β, -0.048; 95% CI, -0.080 to -0.016) than did participants with low physical activity (no reported participation) (β, -0.075; 95% CI, -0.108 to -0.041). For participants with low NfL concentrations (≤25 pg/mL), those who took part in medium physical activity had 43% slower global cognitive decline (β, -0.025; 95% CI, -0.043 to -0.007) and individuals who participated in high physical activity had 30% slower decline (β, -0.031; 95% CI, -0.048 to -0.014) than did those who participated in low physical activity (β, -0.046; 95% CI, -0.066 to -0.025).
Conclusions and relevance
The findings suggest that physical activity is associated with diminished cognitive decline among older adults with increased serum NfL concentrations. The results support the potential use of blood biomarkers in measuring the benefits of health behaviors, such as physical activity, and early intervention for older adults at risk for cognitive decline.
Sources et attribution
Examination of Neurofilament Light Chain Serum Concentrations, Physical Activity, and Cognitive Decline in Older Adults.
Desai P, Dhana K, DeCarli C, Wilson RS, McAninch EA, Evans DA, Rajan KB.
JAMA network open · 2022-03-01
DOI: 10.1001/jamanetworkopen.2022.3596 ↗PubMed · 35315915 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
Exercise gave small-to-moderate cognitive gains across 133 reviews of trials
An umbrella review of 133 systematic reviews (2724 trials, 258,279 participants) found that exercise improved general cognition (SMD 0.42, 95% CI 0.37 to 0.47), memory (0.26) and executive function (0.24), with the largest memory gains in children and adolescents and the largest executive function gains in people with ADHD. Most of the reviews (94) were rated critically low in quality and the effects were smaller in the best-rated ones (0.23 for general cognition), and the outcomes were test scores, not dementia.
British Journal of Sports Medicine
More daily steps linked to fewer depressive symptoms across 33 studies of adults
Pooling 33 observational studies of 96,173 adults, higher daily step counts went with fewer depressive symptoms, and in the two prospective cohorts that could be pooled, 7000 or more steps a day went with a lower risk of depression than fewer (RR 0.69, 95% CI 0.62-0.77). Most studies were cross-sectional, so low mood may be reducing steps as much as steps affect mood, and the authors say the prediction intervals call for caution.
JAMA Network Open
Exercise eased depression in 218 trials, but confidence in the evidence is low
In a network meta-analysis of 218 trials with 14,170 people who met criteria for major depression, walking or jogging, yoga, strength training, mixed aerobic exercise and tai chi or qigong each gave moderate reductions in depression compared with active controls (walking or jogging: Hedges' g −0.62, 95% credible interval −0.80 to −0.45). Confidence in the evidence was low for walking or jogging and very low for the other treatments, mainly because only one study met the low-risk-of-bias criteria.
BMJ
Physical activity eased depression and anxiety across 97 reviews of trials
Across 97 systematic reviews that pooled 1039 randomized trials with 128,119 participants, physical activity had medium effects on depression (median effect size −0.43) and anxiety (−0.42) compared with usual care, and higher-intensity activity went with larger gains. Most of those reviews (77) were rated critically low in quality, and the evidence mainly concerns mild-to-moderate symptoms.
British Journal of Sports Medicine

